CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Biopolitical Times

Cropped from: “Decentralized_Transhumanism” by
Leonel Sohns, CC BY-SA 4.0, via Wikimedia Commons

The techno-utopian credos known as “effective altruism” and “longtermism” have recently gained wide notice, judging by Google searches, news articles, and personal experience. Far less attention has been paid to “hipster eugenics,” a term that brutally but accurately sums up the alarming trend previously known by the perhaps more anodyne “designer babies.” All are closely related.

Effective altruism has been defined rather politely as “a global philanthropic...

Biopolitical Times

The UK Royal Society has published an overview and schedule for the Third International Summit on Human Genome Editing, which will take place on 6–8 March 2023 at the Francis Crick Institute in London. The upcoming event is part of a series of major convenings about human genome editing that has been organized by the national science academies of the US and the UK. Regrettably, this event, like its predecessors, appears to be mostly an opportunity for advocacy in favor...

Biopolitical Times
A stellar panel discussed how to bring a broader and more critical understanding of equity into current societal and public policy conversations about heritable genome editing.

Aggregated News

One day in 2006, Dorothy Roberts went in for a conference with her youngest son’s teacher. The boy, said the...

Biopolitical Times

Image adapted from work by Petr Kratochvil 

Following an annual Biopolitical Times tradition, we present a choice selection of...

Cropped from: “Decentralized_Transhumanism” by
Leonel Sohns, CC BY-SA 4.0, via Wikimedia Commons

The techno-utopian credos known as “effective altruism”...

Three UK advocacy organizations have recently released substantial publications about genetically modified food crops that critically assess their impacts and...

News

Amanda wanted to warn someone. In June 2021, her daughter — the one she and her husband had tried for three years to conceive — had died after only 28 hours. With an underdeveloped nose, she had battled for every...

In a bold attempt to stop the progress of some cases of Alzheimer’s disease, a group of researchers is trying something new — injecting a protective gene into patients’ brains.

The trial involved just five patients with a particular genetic...

The FDA has set out its reasons for putting Verve Therapeutics’ high cholesterol gene editing therapy on hold. Officials want additional data to allay concerns that patients could pass on the edited genes to their children before they lift the...

Some of Steven Pipe’s hemophilia patients consider themselves cured. In a trial Pipe led from 2018 to 2021, they received a one-time gene therapy meant to override a DNA mutation that causes spontaneous bleeding episodes, some of them severe and...

Video

A Dangerous Idea: Eugenics in America
Use Gene Editing to Treat Patients, Not Design Babies
CRISPR: What is the future of gene editing? | Start Here